Neurosense Therapeutics Ltd
NRSN1.170USD
+0.090+8.33%
Market hours （ET）Quotes delayed by 15 min
27.18MMarket Cap
LossP/E TTM
More Details of Neurosense Therapeutics Ltd Company
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Company Info
Ticker SymbolNRSN
Company nameNeurosense Therapeutics Ltd
IPO dateDec 09, 2021
CEOMr. Alon Ben-Noon
Number of employees15
Security typeOrdinary Share
Fiscal year-endDec 09
Address11 Hamenofim St.
CityHERZLIYA
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code4672562
Phone97299531142
Websitehttps://www.neurosense-tx.com/
Ticker SymbolNRSN
IPO dateDec 09, 2021
CEOMr. Alon Ben-Noon
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Ben-Noon (Alon)
13.24%
Rimon Gold Assets Ltd
9.60%
Gordon Ariel S
4.31%
Eisenberg (Or)
2.00%
Tracik (Ferenc)
0.79%
Other
70.05%
Shareholders
Shareholders
Proportion
Ben-Noon (Alon)
13.24%
Rimon Gold Assets Ltd
9.60%
Gordon Ariel S
4.31%
Eisenberg (Or)
2.00%
Tracik (Ferenc)
0.79%
Other
70.05%
Shareholder Types
Shareholders
Proportion
Individual Investor
21.38%
Corporation
9.60%
Investment Advisor
0.29%
Research Firm
0.21%
Venture Capital
0.14%
Hedge Fund
0.11%
Investment Advisor/Hedge Fund
0.07%
Other
68.21%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
37
7.63M
31.79%
+136.65K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
2023Q2
33
6.46M
53.11%
+1.06M
2023Q1
30
5.11M
43.34%
-185.85K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Ben-Noon (Alon)
3.18M
13.24%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
9.6%
+2.30M
--
Dec 02, 2024
Gordon Ariel S
1.03M
4.31%
+1.30K
+0.13%
Dec 31, 2023
Eisenberg (Or)
480.92K
2%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.79%
+66.67K
+54.22%
Apr 07, 2025
Russek-Blum (Niva)
75.43K
0.31%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.27%
--
--
Apr 07, 2025
Morgan Stanley & Co. LLC
50.50K
0.21%
-52.08K
-50.77%
Mar 31, 2025
Meitav Dash Investments Ltd.
40.00K
0.17%
--
--
Mar 31, 2025
XTX Markets LLC
33.71K
0.14%
-8.19K
-19.55%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
